Hide Board Information

Show Board Information

CPI Corp. CPICQ

Board Mod: Add me as mod

Asst Mods:

Last Post: 07/15/2014 11:19:16 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 4

CPI Corp. (OTCMRKTS: CPICQ) Stock Message Board

1. CPICQ Company Profile

    

2. CPICQ Time & Sales

    

3. CPICQ Recent News

    

4. CPICQ Filings

    

5. CPICQ Financials

    

6. CPICQ Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

3	CPICQ Financials 07/15/2014 22:19:18 CPI Corp.	Emylers	07/15/2014 11:19:16 PM
2	CPICQ 0.0053 Stock Charts $CPICQ 1 Month Chart	chartguy89	03/06/2014 2:32:43 PM
1	CPICQ Stock Charts Last: +0.0083 Monday, February	chartguy89	02/24/2014 10:47:01 PM

Recent Articles

• Sobi Adjusts Revenue Forecast for 2025 Amid Strong Q3 Growth
• Sobi Updates Full-Year Outlook and Q3 2025 Financial Report
• Exploring NB HASH and the Transformation of Wealth Today
• Kevin Hart's Journey From Investment Missteps to Business Success
• BlackRock's Strategic Shift: The Future of Investment in RWA
• Major Contract Termination Announced by Vantage Drilling
• Deadline Approaches for Dow Inc. Investors Amid Legal Action
• Important Update for Cepton, Inc. Investors on Class Action
• Target and Walmart Thrive Amid Collectible Card Sales Surge
• Snap Investors Urged to Consider Leading Legal Action
• Unlocking Wealth Potential: The RWA Revolution Explained
• Embracing Real-World Assets with NB HASH for Sustainable Growth
• Nutex Health Investors Can Join Class Action Against Company
• Potential Legal Action for Baxter International Investors
• Solidarity in Aviation: Airline Workers Support Controllers
• Class Action Lawsuit Against MoonLake Immunotherapeutics Investors
• Promising Outcomes Unveiled from HARMONi-6 Clinical Study
• Exploring Cadonilimab's Promising Results in Advanced Gastric Cancer
• Tech Giants Reshape Manufacturing Strategies Amid Market Shifts
• Promising Findings on Subcutaneous Amivantamab for Cancer
• Vivace Therapeutics Reports Promising Results for VT3989 Therapy
• iOncologi's Patent Enhances Cancer Treatment with mRNA Breakthrough
• Innovative Subcutaneous Therapy Shows Promise in Cancer Treatment
• New Breakthrough Data from Novartis on Prostate Cancer Treatment
• Transforming Assets: The Role of NB HASH in Digital Wealth
• The Future of Wealth: Bridging Real-World Assets with Blockchain
• Avacta Therapeutics Reveals Promising Phase 1a Results for FAP-Dox
• Significant Phase 1a Trial Findings for Faridoxorubicin
• Major Developments in AI: Insights from Top Tech Executives
• Celebrating Five Years of Innovations at United Imaging's Hub
• International Engagement Highlighted at Financial Forum 2025
• Crypto World Buzzes: Ripple's Fund, Bitcoin's Future & More
• Max Stock Limited Reveals Holdings of Key Parties and Officers
• China's Revolutionary Advances in Solid-State Battery Tech
• Biggest Weekly Losers: Insights on IonQ and Tempus AI Stocks
• Revolutionizing Startup Insight with AI: Startuprad.io's New Tool
• Revolutionizing Patient Care with AI: HDAI's Innovative Approach
• Top Gainers in the Market: D-Wave, Estée Lauder & Others
• Empowering Higher Education Payroll Professionals at EIPC
• SystImmune's Iza-bren Shows Promising Results in Cancer Trial
• Latest Developments in the Auto Industry and Technology Advancements
• RAPT Therapeutics Set to Unveil Key Clinical Findings Soon
• Tech Industry Update: Innovations, Earnings, and Future Trends
• Mutuum Finance Advances Plans for Testnet Launch in 2025
• Replimune Showcases Promising Results for Acral Melanoma
• Exciting Developments in RAPT Therapeutics' Clinical Trials
• Are Aliens Now More Likely Than Bitcoin Reaching $200,000?
• Apple's New F1 Streaming Deal and Exciting Recent Developments
• World Winter Sports Expo 2025: A New Era for the Industry
• Alibaba Cloud Revolutionizes AI with Aegaeon System Efficiency